Metraipolis › archive › dc_45da0aebad99

Homologous recombination deficiency in breast cancer: genomic characteristics, clinical implications, and predictive value in neoadjuvant therapy — Europe PMC PMID:41122659

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41122659
DOI
10.3389/fonc.2025.1608968
License (as archived)
solo-consultazione
Archived
2026-11-09T13:44:26.149Z
SHA-256 of the archived text
7e435cbccd8adaf5615760a29bf903f68e2a2768e6b9d81ccfa9262bdb4fe895
Stable URL of this page
https://metraipolis.com/documento/dc_45da0aebad99

How to cite

Homologous recombination deficiency in breast cancer: genomic characteristics, clinical implications, and predictive value in neoadjuvant therapy — Europe PMC PMID:41122659 — Europe PMC (en), https://europepmc.org/article/MED/41122659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45da0aebad99 (Metraipolis archive dc_45da0aebad99, sha256 7e435cbccd8adaf5615760a29bf903f68e2a2768e6b9d81ccfa9262bdb4fe895)
BibTeX
@misc{dc45da0aebad99,
  title = {Homologous recombination deficiency in breast cancer: genomic characteristics, clinical implications, and predictive value in neoadjuvant therapy — Europe PMC PMID:41122659},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41122659},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45da0aebad99; sha256 7e435cbccd8adaf5615760a29bf903f68e2a2768e6b9d81ccfa9262bdb4fe895},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122659. Agents can read the archived copy with the MCP tool read_document.